Canterbury DHB


Tumour Lysis Syndrome

Patients with extensive Burkitt-like lymphoma/leukaemia, AML, and ALL with high tumour burden, are most likely to suffer this complication. For full information and recommended treatment, see Tumour Lysis Syndrome in the supportive care section.

About this Canterbury DHB document (11672):

Document Owner:

Steve Gibbons and Fiona Stone (see Who's Who)

Issue Date:

March 2017

Next Review:

March 2020


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 11672